Work

β-Cyclodextrin-Modified Methylene Blue–Alginate Microgels by Droplet Microfluidics for Antibacterial Photodynamic Therapy

Year: 2026
Type: article
Abstract: Antimicrobial photodynamic therapy offers a route to bacterial inactivation that does not depend on conventional resistance mechanisms, and methylene blue (MB) is among the most established photosensitizers. Its efficiency, however, is governed by aggregation state: only monomeric MB generates singlet oxygen efficiently, while the dimers that form within negatively charged carriers such as alginate are photodynamically inactive. Here, we report a droplet-microfluidic platform for fabricating monodisperse MB-loaded calcium alginate microgels and exploit β-cyclodextrin (β-CD) co-encapsulation to control the monomer fraction of the released dye. Internal-gelation flow-focusing produced uniform microgels (∼132 µm; coefficient of variation 2.1%), within which increasing β-CD content progressively raised the monomeric fraction of the released MB, as quantified by the A664/A610 absorbance ratio. Photosensitized ROS generation under 630 nm irradiation, measured with 1,3-diphenylisobenzofuran in a medium that preserves MB aggregation, was 1.9-fold higher for the β-cyclodextrin formulation, and the microgels produced clear, light-dependent killing of Staphylococcus aureus and Escherichia coli. β-Cyclodextrin co-encapsulation significantly enhanced bactericidal activity against S. aureus (p < 0.01), with the same trend in E. coli. By making photosensitizer monomer fraction, dose, and carrier geometry separately measurable and tunable within a single monodisperse platform, this work provides a route toward the rational optimization of photodynamic antibacterial microgels.
Language: English
Subfield: Cancer Research
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7235266240
FWCI:
Cites: 45
Cited by:
Related to: 10